Pretreatment of MMTV-human HER2 transgenic mice with mu4D5 significantly reduces mammary tumor incidence.

被引：0

|

作者：

Quan, Z ^{[1
]}

Finkle, D ^{[1
]}

Asghari, V ^{[1
]}

Kloss, J ^{[1
]}

Koeppen, H ^{[1
]}

Hall, L ^{[1
]}

Yang, N ^{[1
]}

Stephan, J ^{[1
]}

Wong, W ^{[1
]}

Sliwkowski, MX ^{[1
]}

Erickson, SL ^{[1
]}

机构：

[1] Genentech Inc, S San Francisco, CA 94080 USA

来源：

CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

251

引用

收藏

页码：3703S / 3703S

页数：1

相关论文

共 4 条

[1] Co-expression of human prolactin drastically reduces breast cancer incidence in HER2/neu transgenic mice
Scotti, Michele L.
Peirce, Susan K.
Tomblyn, Seth
Derrick, Blake
Langenheim, John
Jacquemart, Isabelle
Park, Jang Pyo
Chen, Wen
[J]. CANCER RESEARCH, 2006, 66 (08)
[2] HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice
Finkle, D
Quan, ZR
Asghari, V
Kloss, J
Ghaboosi, N
Mai, E
Wong, WL
Hollingshead, P
Schwall, R
Koeppen, H
Erickson, S
[J]. CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2499 - 2511
[3] Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
Ladjemi, Maha Z.
Chardes, Thierry
Corgnac, Stephanie
Garambois, Veronique
Morisseau, Sebastien
Robert, Bruno
Bascoul-Mollevi, Caroline
Arsa, Imade Ait
Jacot, William
Pouget, Jean-Pierre
Pelegrin, Andre
Navarro-Teulon, Isabelle
[J]. BREAST CANCER RESEARCH, 2011, 13 (01):
[4] Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
Maha Z Ladjemi
Thierry Chardes
Stephanie Corgnac
Veronique Garambois
Sebastien Morisseau
Bruno Robert
Caroline Bascoul-Mollevi
Imade Ait Arsa
William Jacot
Jean-Pierre Pouget
Andre Pelegrin
Isabelle Navarro-Teulon
[J]. Breast Cancer Research, 13